-

ITC: ITC nozzle spray to protect against Kovid.. Clinical trial started.. | ITC begins clinical trial of nasal spray for prevention of COVID 19

HealthITC: ITC nozzle spray to protect against Kovid.. Clinical...

ITC

ITC said that it is developing a nasal spray for the prevention of Kovid-19. ITC on Thursday confirmed that clinical trials have started for this. Developed by scientists at ITC Life Sciences and Technology Center (LSTC) in Bangalore. After obtaining all the necessary regulatory approvals, the company plans to market the nozzle spray under the Savlon brand. “We are unable to share full details because the nasal spray is currently undergoing clinical trials.” ITC spokesperson said.

“Where the clinical trial is taking place. Where production takes place after approval. A spokesperson declined to comment on which brand the nozzle spray will be sold with. However, approval has been received from the ethics committees for clinical trials. The clinical trial to this extent has been registered with the Registry-India (CTRI), sources said. It is said that this spray works effectively in preventing the spread of corona. However, apart from spray, other covid rules will have to be followed.

READ MORE  Corona virus: Corona havoc in the area.. winter is coming.. It has been warned that if people are careless then lakhs of people can die. WHO warns of 700,000 more COVID deaths in Europe by March

Also read.. Nitin Gadkari: EV revolution around.. Prices of electric vehicles will come down in two years.

,

Latest news

You might also likeRELATED
Recommended to you